Management and prognosis of systemic lupus erythematosus.
D000477:Alkylating Agents / Q000008:administration & dosage; D000962:Antimalarials / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007213:Indomethacin / Q000008:administration & dosage; D016030:Kidney Transplantation; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D010653:Phenylbutazone / Q000008:administration & dosage; D011379:Prognosis; D012146:Rest; D012459:Salicylates / Q000008:administration & dosage; D013472:Sunlight; D013934:Thymectomy; D014184:Transplantation, Homologous
D000477:Alkylating Agents; D000962:Antimalarials; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D012459:Salicylates; D010653:Phenylbutazone; D007213:Indomethacin